{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:57:48Z","timestamp":1762160268289},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[1982]]},"DOI":"10.1007\/bf00541162","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T03:47:15Z","timestamp":1100836035000},"page":"107-111","source":"Crossref","is-referenced-by-count":38,"title":["Altered thiol status in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"2","author":[{"given":"J. C.","family":"Banford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. H.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Hazelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"Sturrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","volume-title":"Biochemistry of the SH group","author":"PC Jocelyn","year":"1972","unstructured":"Jocelyn PC (1972) Biochemistry of the SH group. Academic Press, London New York"},{"key":"CR2","first-page":"73","volume":"36","author":"M Haataja","year":"1977","unstructured":"Haataja M, Kalliomaki JL, (1977) Serum sulphydryl groups in rheumatoid arthritis. Z. Rheumatol 36:73?76","journal-title":"Z. Rheumatol"},{"key":"CR3","doi-asserted-by":"crossref","unstructured":"Lorber A, Bovy RA, Chang CC (1971) Sulphydryl deficiency. In: Connective tissue disorders: Correlation with disease activity and protein alterations. Metabolism 20:446?455","DOI":"10.1016\/0026-0495(71)90120-X"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-61-3-423","volume":"61","author":"A Lorber","year":"1964","unstructured":"Lorber A, Pearson CM, Meredith WL, Gantz-Mandell LE, (1964) Serum sulphydryl determinations and significance in connective tissue diseases. Ann Intern Med 61:423?433","journal-title":"Ann Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/03009747909108228","volume":"28","author":"E Munthe","year":"1979","unstructured":"Munthe E, Jellum E, Aaseth J (1979) Some aspects of the mechanism of penicillamine in rheumatoid arthritis. Scand J Rheumatol (Suppl) 28:6?12","journal-title":"Scand J Rheumatol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1039\/cs9800900217","volume":"9","author":"DH Brown","year":"1980","unstructured":"Brown DH, Smith WE (1980) The chemistry of the gold drugs used in the treatment of rheumatoid arthritis. Chem Soc Rev 9:217?240","journal-title":"Chem Soc Rev"},{"key":"CR7","volume-title":"Albumin: Structure, function and uses","author":"JF Foster","year":"1977","unstructured":"Foster JF, (1977) Some aspects of the structure and conformational properties of serum albumin. In: Rosenoer VM, Murray O, Rothschild MA (eds) Albumin: Structure, function and uses. Pergamon, New York"},{"key":"CR8","first-page":"95","volume":"70","author":"PH Evans","year":"1977","unstructured":"Evans PH (1977) Serum sulphydryl changes in rheumatoid coalworkers' pneumoconiosis patients treated with D-penicillamine. Proc R Soc Med 70:95?97","journal-title":"Proc R Soc Med"},{"key":"CR9","volume-title":"The chemistry and biochemistry of the sulphydryl group in amino acids, peptides and proteins","author":"M Friedman","year":"1973","unstructured":"Friedman M (1973) The chemistry and biochemistry of the sulphydryl group in amino acids, peptides and proteins. Pergamon, London"},{"key":"CR10","unstructured":"Banford JC, McNeil CJ, Brown DH, Smith WE Unpublished work"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.18.1.49","volume":"18","author":"MW Ropes","year":"1959","unstructured":"Ropes MW, Bennett GA, Cobb S, Jacob R, Jesser RA (1959) Diagnostic criteria for rheumatoid arthritis. Ann Rheum Dis 18: 49?53","journal-title":"Ann Rheum Dis"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL, (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82:49?53","journal-title":"Arch Biochem Biophys"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1039\/an9780300921","volume":"103","author":"H Kamel","year":"1978","unstructured":"Kamel H, Teape J, Brown DH, Ottaway JM, Smith WE (1978) Determination of copper in plasma ultrafiltrate by AAS using carbon furnace atomisation. Analyst 103:921?927","journal-title":"Analyst"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.38.2.174","volume":"38","author":"DH Brown","year":"1979","unstructured":"Brown DH, Buchanan WW, El-Ghobary A, Smith WE, Teape J (1979) Serum copper and its relationship to clinical symptoms in rheumatoid arthritis. Ann Rheum Dis 38:174?176","journal-title":"Ann Rheum Dis"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0003-9861(77)90509-4","volume":"181","author":"HP Misra","year":"1977","unstructured":"Misra HP, Fridovich I (1977) Superoxide dismutase: a photochemical augmentation assay. Arch Biochem Biophys 181: 308?312","journal-title":"Arch Biochem Biophys"},{"key":"CR16","volume-title":"Inflammation: Mechanisms and treatment","author":"WE Smith","year":"1981","unstructured":"Smith WE, Brown DH, Dunlop J, Hazelton RA, Sturrock RD, Lewis AJ (1981) The effect of therapeutic agents on serum copper levels and serum oxidase activities in the rat adjuvant model compared to analogous results from studies of rheumatoid arthritis in humans. In: Willoughby DA, Giroud JP (eds) Inflammation: Mechanisms and treatment. M.T. Press, London"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/S0021-9258(18)97059-6","volume":"240","author":"MJ Stansell","year":"1965","unstructured":"Stansell MJ, Deutsch HF (1965) Preparation of crystalline erythrocuprein and catalase from human erythrocytes. J Biol Chem 240:4299?4305","journal-title":"J Biol Chem"},{"key":"CR18","first-page":"79","volume":"3","author":"V Albergoni","year":"1978","unstructured":"Albergoni V, Cassini A (1978) The oxidation of sulphydryl compounds by caeruloplasmin. Bull Mol Biol Med 3:79?85","journal-title":"Bull Mol Biol Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.2042-7158.1980.tb12920.x","volume":"32","author":"ME Pickup","year":"1980","unstructured":"Pickup ME, Dixon JS, Bird HA (1980) On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum. J Pharm Pharmacol 32:301?302","journal-title":"J Pharm Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/art.1780200615","volume":"20","author":"DA Gerber","year":"1977","unstructured":"Gerber DA, Shum K (1977) Histidine inhibition of the oxidation of serum protein sulphydryl groups. Arthritis Rheum 20:116","journal-title":"Arthritis Rheum"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI102899","volume":"33","author":"M Ropes","year":"1954","unstructured":"Ropes M, Perlmann GE, Kaufman D, Bauer W (1954) Electrophoretic distribution of proteins in plasma in rheumatoid arthritis. J Clin Invest 33:311?318","journal-title":"J Clin Invest"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0009-8981(75)90132-1","volume":"60","author":"J Thomas","year":"1975","unstructured":"Thomas J, Evans PH (1975) Serum protein changes in coal-workers' pneumoconiosis. Clin Chim Acta 60:237?247","journal-title":"Clin Chim Acta"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"L 21","DOI":"10.1016\/S0020-1693(00)85762-X","volume":"66","author":"JC Banford","year":"1982","unstructured":"Banford JC, Brown DH, McNeil CJ, Smith WE (1982) Differences in the reaction of D-penicillamine and L-cysteine with 5,5?-dithiobis (2-nitrobenzoic acid). A model for some in vivo differences? Inorg Chim Acta 66:L 21?22","journal-title":"Inorg Chim Acta"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.2042-7158.1979.tb13627.x","volume":"31","author":"ND Hall","year":"1979","unstructured":"Hall ND, Gillan AH (1979) Effect of anti-rheumatic drugs on protein SH reactivity of human serum. J Pharm Pharmacol 31:676?680","journal-title":"J Pharm Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","volume":"59","author":"B Chance","year":"1979","unstructured":"Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527?605","journal-title":"Physiol Rev"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(79)92520-0","volume":"II","author":"E Munthe","year":"1979","unstructured":"Munthe E, Guldal G, Jellum E (1979) Increased intracellular glutathione during penicillamine treatment for rheumatoid arthritis. Lancet II:1126?1127","journal-title":"Lancet"},{"key":"CR27","volume-title":"Trace elements in the pathogenesis and treatment of inflammation","author":"DA Gerber","year":"1980","unstructured":"Gerber DA (1980) Possible role of a copper complex in the pathogenesis of rheumatoid arthritis. In: Rainsford KD, Brune K, Whitehouse MW (eds) Trace elements in the pathogenesis and treatment of inflammation. Birkh\u00e4user, Basel"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00541162\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00541162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T02:54:28Z","timestamp":1624935268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00541162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982]]}},"alternative-id":["BF00541162"],"URL":"https:\/\/doi.org\/10.1007\/bf00541162","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}